P366 Developing an in-house and integrated sweat testing service for the routine management of adults with cystic fibrosis

Abstract

Listen

Translate article

Since 1959, the sweat test has become an essential diagnostic test for cystic fibrosis (CF). In 2012, the CFTR potentiator, ivacaftor became available on the National Health Service (NHS) in England. Commissioning guidance advised that all eligible patients should have a sweat test within 6 months of starting treatment and then at least annually. Historically at Leeds Teaching Hospitals NHS Trust, sweat tests were performed by the biomedical team.